CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Influenza vaccinebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04122222
NCT04122222N/ACompleted
CompareCT.gov

Immune Response to Influenza Vaccination in ESRD Patients Undergoing Hemodialysis vs. Hemodiafiltration

Mahidol University·interventional·Posted Oct 10, 2019·Updated Oct 10, 2019

In Brief

A clinical study evaluating Influenza vaccine for Immunology and Nephrology. Completed, enrolled 60 participants.

Detailed Summary

On-line hemodiafiltration (HDF) clears more azotaemic toxins compared to high-flux hemodialysis (HD). The response to vaccination is impaired in dialysis patients. We aimed to study the immune responses to influenza vaccine in dialysis patients treated by HDF vs. HD.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsImmunology, Nephrology
Countries--
CollaboratorsBhumirajanagarindra Kidney Institute, Thailand, Ministry of Health, Thailand

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 10, 2019
Enrollment StartAug 25, 2016
Primary CompletionJul 20, 2018
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 6.7 years ago

Interventions

Influenza vaccinebiological

A single standard dose of inactivated trivalent influenza vaccine: Influvac® vaccines (Abbott, the Netherlands), intramuscularly.